Oncology is a perfect fit for the bundled payment model, because it evaluates the outcomes, patient satisfaction, and cost of an oncology episode, said Kim Eason, manager at Horizon Blue Cross Blue Shield of NJ. She said that Horizon adopted the bundled payment model early to cope with New Jersey’s rising healthcare costs.
Oncology is a perfect fit for the bundled payment model, because it evaluates the outcomes, patient satisfaction, and cost of an oncology episode, said Kim Eason, manager at Horizon Blue Cross Blue Shield of NJ. She said that Horizon adopted the bundled payment model early to cope with New Jersey’s rising healthcare costs.
Transcript (slightly modified)
How can episode-based, or bundled, payments improve value and quality in cancer care?
We believe that episode-based payment can improve payments in any type of model, any type of specialty, and oncology care is no different from that. As we look at the shift in changing from fee-for-service to value-based care, oncology fits that model perfectly because it does look at specific services and events that happen to a patient along their care continuum, so we have the opportunity at Horizon to evaluate the total cost of care that patient is receiving within the oncology episode, their outcomes, and then their overall patient satisfaction.
Adoption of bundled payments has so far been fairly slow. Why did Horizon Blue Cross Blue Shield jump in so quickly?
The episode payment model, the reform, it’s really an evolution and not a revolution. So being slow doesn’t surprise us or surprise me, we believe it will take time for those changes to take place. But Horizon knew that inevitably something had to change. New Jersey has the 2nd highest healthcare cost in the nation and we could not continue to just look at cost rising and not figure out ways to address that, and then we decided to build our models around patient satisfaction, quality of care, and then the total cost of care. So that’s the reason why Horizon jumped in, because we knew we wanted to be there as the ground was breaking and not at the end of the event.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More
Proposed SNAP Cuts Could Threaten Prevention for Cognitive Decline, Dementias
July 30th 2025Supplemental Nutrition Assistance Program (SNAP) benefits may slow cognitive decline in older adults, highlighting the importance of food assistance in combating Alzheimer disease and dementia risks.
Read More